SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin recalls blood pressure drug from US

09 Aug 2011 Evaluate

Drug firm Lupin is recalling one batch of Losartan Potassium Tablets, used in treating high blood pressure, from the US market for exceeding permissible impurity level.  According to the US Food and Drug Administration (USFDA) in its enforcement report, Indian firm was recalling a batch of 34,368 bottlesas the drug did not meet specification for impurities at the nine-month stability station. The batch, which is being recalled, was due to expire in July next year. The company produces the drug at its Goa facility. The recall falls under the FDA's class II category which means that the use of the drug may cause temporary or medically reversible adverse health consequences, but unlikely to have serious adverse health consequences.crackcrack

Lupin Share Price

2324.25 -2.25 (-0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×